Jiangsu Favored Nanotechnology Co. Ltd. A (688371) - Total Liabilities

Latest as of March 2026: CN¥140.31 Million CNY ≈ $20.53 Million USD

Based on the latest financial reports, Jiangsu Favored Nanotechnology Co. Ltd. A (688371) has total liabilities worth CN¥140.31 Million CNY (≈ $20.53 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Jiangsu Favored Nanotechnology Co. Ltd. to track the company's year-over-year net asset growth rate.

Jiangsu Favored Nanotechnology Co. Ltd. A - Total Liabilities Trend (2020–2025)

This chart illustrates how Jiangsu Favored Nanotechnology Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. See 688371 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Jiangsu Favored Nanotechnology Co. Ltd. A Competitors by Total Liabilities

The table below lists competitors of Jiangsu Favored Nanotechnology Co. Ltd. A ranked by their total liabilities.

Company	Country	Total Liabilities
Northking Information Technology Co SHE:002987	China	CN¥586.97 Million
Ardent Health Partners, Inc. NYSE:ARDT	USA	$3.52 Billion
Beijing Gehua CATV Network Co Ltd SHG:600037	China	CN¥2.84 Billion
Zillow Group Inc NASDAQ:ZG	USA	$818.00 Million
Srisawad Power 1979 PCL BK:SAWAD	Thailand	฿66.92 Billion
CONSUN PHARMAC.GR.HD -10 F:C1P	Germany	€1.57 Billion
Hotel101 Global Holdings Corp. Class A Ordinary Shares NASDAQ:HBNB	USA	$135.19 Million
Chongqing Zaisheng Tech Corp SHG:603601	China	CN¥861.86 Million

Liability Composition Analysis (2020–2025)

This chart breaks down Jiangsu Favored Nanotechnology Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688371 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	8.42	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.07	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.07	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jiangsu Favored Nanotechnology Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jiangsu Favored Nanotechnology Co. Ltd. A (2020–2025)

The table below shows the annual total liabilities of Jiangsu Favored Nanotechnology Co. Ltd. A from 2020 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥155.26 Million ≈ $22.72 Million	+24.18%
2024-12-31	CN¥125.03 Million ≈ $18.30 Million	-9.24%
2023-12-31	CN¥137.75 Million ≈ $20.16 Million	+27.97%
2022-12-31	CN¥107.64 Million ≈ $15.75 Million	-61.30%
2021-12-31	CN¥278.15 Million ≈ $40.70 Million	+162.57%
2020-12-31	CN¥105.93 Million ≈ $15.50 Million	--

About Jiangsu Favored Nanotechnology Co. Ltd. A

SHG:688371 China Specialty Chemicals

Market Cap

$1.35 Billion

CN¥9.20 Billion CNY

Market Cap Rank

#7558 Global

#1617 in China

Share Price

CN¥27.43

Change (1 day)

+19.99%

52-Week Range

CN¥16.46 - CN¥45.05

All Time High

CN¥45.05